Literature DB >> 30382560

The effect of polymorphism of uric acid transporters on uric acid transport.

Ze Wang1, Tao Cui1, Xiaoyan Ci2, Fang Zhao1, Yinghui Sun1, Yazhuo Li3, Rui Liu1, Weidang Wu4, Xiulin Yi5,6, Changxiao Liu1,2,3.   

Abstract

The abnormal metabolism of uric acid results in many disease such as chronic kidney disease, hyperuricemia, nephrolithiasis, gout, hypertension, vascular disease and so on. Serum uric acid levels are maintained by the balance between production and elimination. There are many factors that maintain the balance of serum uric acid. One of them is transporters which are responsible for the debouchment of uric acid within blood. The transport and excretion of uric acid is a complicated procedure which is related with various transporters such as OAT1, OAT3, OAT4, URAT1, GLUT9, BCRP, MRP4, NPT1, NTP4, and so on. In recent years, a large number of genome-wide association studies have shown that the single nucleotide polymorphisms of uric acid transporters were closely related to serum uric acid level. What's more, some mutations on these gene locus may also break the balance of serum uric acid. Here, the polymorphisms of uric acid transporters closely related with the serum uric acid balance were reviewed and discussed because of their important significance in clinical therapy for a precision medicine. The mechanism of metabolic diseases with gene variation may provide new strategy for the design and development of innovative drug to treat diseases with uric acid metabolic disturbance.

Entities:  

Keywords:  Gene polymorphisms; Hyperuricemia; Transporters; Uric acid

Mesh:

Substances:

Year:  2018        PMID: 30382560     DOI: 10.1007/s40620-018-0546-7

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  70 in total

1.  Human renal organic anion transporter 4 operates as an asymmetric urate transporter.

Authors:  Yohannes Hagos; Daniel Stein; Bernhard Ugele; Gerhard Burckhardt; Andrew Bahn
Journal:  J Am Soc Nephrol       Date:  2007-01-17       Impact factor: 10.121

2.  Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout.

Authors:  J Vázquez-Mellado; A L Jiménez-Vaca; S Cuevas-Covarrubias; V Alvarado-Romano; G Pozo-Molina; R Burgos-Vargas
Journal:  Rheumatology (Oxford)       Date:  2006-07-11       Impact factor: 7.580

3.  Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population.

Authors:  Juergen Graessler; Anett Graessler; Susette Unger; Steffi Kopprasch; Anne-Kathrin Tausche; Eberhard Kuhlisch; Hans-Egbert Schroeder
Journal:  Arthritis Rheum       Date:  2006-01

4.  Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins.

Authors:  Hiroki Miyazaki; Naohiko Anzai; Sophapun Ekaratanawong; Takeshi Sakata; Ho Jung Shin; Promsuk Jutabha; Taku Hirata; Xin He; Hiroshi Nonoguchi; Kimio Tomita; Yoshikatsu Kanai; Hitoshi Endou
Journal:  J Am Soc Nephrol       Date:  2005-10-19       Impact factor: 10.121

5.  Avian renal proximal tubule epithelium urate secretion is mediated by Mrp4.

Authors:  Amy M Bataille; James Goldmeyer; J Larry Renfro
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-22       Impact factor: 3.619

6.  Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.

Authors:  Abbas Dehghan; Anna Köttgen; Qiong Yang; Shih-Jen Hwang; Wh Linda Kao; Fernando Rivadeneira; Eric Boerwinkle; Daniel Levy; Albert Hofman; Brad C Astor; Emelia J Benjamin; Cornelia M van Duijn; Jacqueline C Witteman; Josef Coresh; Caroline S Fox
Journal:  Lancet       Date:  2008-10-01       Impact factor: 79.321

7.  SLC2A9 influences uric acid concentrations with pronounced sex-specific effects.

Authors:  Angela Döring; Christian Gieger; Divya Mehta; Henning Gohlke; Holger Prokisch; Stefan Coassin; Guido Fischer; Kathleen Henke; Norman Klopp; Florian Kronenberg; Bernhard Paulweber; Arne Pfeufer; Dieter Rosskopf; Henry Völzke; Thomas Illig; Thomas Meitinger; H-Erich Wichmann; Christa Meisinger
Journal:  Nat Genet       Date:  2008-03-09       Impact factor: 38.330

8.  Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia.

Authors:  Hirotaka Matsuo; Toshinori Chiba; Shushi Nagamori; Akiyoshi Nakayama; Hideharu Domoto; Kanokporn Phetdee; Pattama Wiriyasermkul; Yuichi Kikuchi; Takashi Oda; Junichiro Nishiyama; Takahiro Nakamura; Yuji Morimoto; Keiko Kamakura; Yutaka Sakurai; Shigeaki Nonoyama; Yoshikatsu Kanai; Nariyoshi Shinomiya
Journal:  Am J Hum Genet       Date:  2008-11-20       Impact factor: 11.025

9.  Mutations in the SLC2A9 gene cause hyperuricosuria and hyperuricemia in the dog.

Authors:  Danika Bannasch; Noa Safra; Amy Young; Nili Karmi; R S Schaible; G V Ling
Journal:  PLoS Genet       Date:  2008-11-07       Impact factor: 5.917

10.  Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI.

Authors:  Anita Brandstätter; Stefan Kiechl; Barbara Kollerits; Steven C Hunt; Iris M Heid; Stefan Coassin; Johann Willeit; Ted D Adams; Thomas Illig; Paul N Hopkins; Florian Kronenberg
Journal:  Diabetes Care       Date:  2008-05-16       Impact factor: 19.112

View more
  9 in total

1.  Tubular injury in diabetic ketoacidosis: Results from the diabetic kidney alarm study.

Authors:  Federica Piani; Isabella Melena; Cameron Severn; Linh T Chung; Carissa Vinovskis; David Cherney; Laura Pyle; Carlos A Roncal-Jimenez; Miguel A Lanaspa; Arleta Rewers; Daniël H van Raalte; Wassim Obeid; Chirag Parikh; Robert G Nelson; Meda E Pavkov; Kristen J Nadeau; Richard J Johnson; Petter Bjornstad
Journal:  Pediatr Diabetes       Date:  2021-09-06       Impact factor: 4.866

2.  The serum uric acid/creatinine ratio is associated with nonalcoholic fatty liver disease in the general population.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  J Physiol Biochem       Date:  2022-05-12       Impact factor: 4.158

3.  Tea (Camellia sinensis) Ameliorates Hyperuricemia via Uric Acid Metabolic Pathways and Gut Microbiota.

Authors:  Dan Wu; Ruohong Chen; Qiuhua Li; Xingfei Lai; Lingli Sun; Zhenbiao Zhang; Shuai Wen; Shili Sun; Fanrong Cao
Journal:  Nutrients       Date:  2022-06-27       Impact factor: 6.706

4.  Association Between Serum Uric Acid Levels and Traditional Cardiovascular Risk Factors in Xiamen Residents of China: A Real-World Study.

Authors:  Peng Zhang; Linjian Chen; Zhaokai Li; Wei Ni; Lin Wang; Wanchun Mei; Guoqiang Ruan; Zaixing Shi; Cuilian Dai
Journal:  Front Cardiovasc Med       Date:  2022-05-17

5.  Isoorientin exerts a urate-lowering effect through inhibition of xanthine oxidase and regulation of the TLR4-NLRP3 inflammasome signaling pathway.

Authors:  Meng-Fei An; Ming-Yue Wang; Chang Shen; Ze-Rui Sun; Yun-Li Zhao; Xuan-Jun Wang; Jun Sheng
Journal:  J Nat Med       Date:  2020-11-13       Impact factor: 2.343

6.  Functional Characterization of Rare Variants in OAT1/SLC22A6 and OAT3/SLC22A8 Urate Transporters Identified in a Gout and Hyperuricemia Cohort.

Authors:  Jiří Vávra; Andrea Mančíková; Kateřina Pavelcová; Lenka Hasíková; Jana Bohatá; Blanka Stibůrková
Journal:  Cells       Date:  2022-03-22       Impact factor: 6.600

Review 7.  Susceptibility genes of hyperuricemia and gout.

Authors:  Yue-Li Nian; Chong-Ge You
Journal:  Hereditas       Date:  2022-08-04       Impact factor: 2.595

Review 8.  The Good, the Bad and the New about Uric Acid in Cancer.

Authors:  Simone Allegrini; Mercedes Garcia-Gil; Rossana Pesi; Marcella Camici; Maria Grazia Tozzi
Journal:  Cancers (Basel)       Date:  2022-10-10       Impact factor: 6.575

Review 9.  Modulation of Urate Transport by Drugs.

Authors:  Péter Tátrai; Franciska Erdő; Gabriella Dörnyei; Péter Krajcsi
Journal:  Pharmaceutics       Date:  2021-06-17       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.